Stocks
ResMed (RMD) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 32.9 | 26.6 | 24.6 | 0.41 | 19.6 | 12.8 | ||
| Changes by years, y/y, % | +14% | -19% | -7% | -98% | +4 628% | -7.4% | |||
ResMed. EV/EBITDA
ResMed. EV/EBITDA, changes, %
ResMed (RMD) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | LTM ? | |||
| EV/EBITDA | ? | 18.7 | 19.5 | 19.9 | 16.8 | 14.7 | 12.8 | |
| Changes by years, y/y, % | +2 893% | +4 527% | -11% | -15% | -21% | |||
| Changes by quarters, q/q, % | -6% | +4% | +2% | -16% | -13% | |||
